Genmont Biotech Inc. (3164)
Market Closed
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
16. 95
+0.05
+0.2959%
NT$
1.59B Market Cap
- P/E Ratio
0.8% Div Yield
19,472 Volume
- Eps
NT$ 16.9
Previous Close Want to track 3164 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Genmont Biotech Inc. (3164) Statistics
Valuation metrics
Market Cap 1.59B
Enterprise value 1.48B
Trailing P/E (ttm) 20.93
Forward P/E -
PEG ratio 0.06
Price/Sales (ttm) 3.82
Price/Book (mrq) 1.12
Enterprise Value/Revenue 3.88
Enterprise Value/EBITDA 12.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 35.15K
Average volume (90 days) 25.72K
Price summary
52-Week low 15.35
52-Week high 19.75
Beta -
50-Day moving average 16.09
200-Day moving average 16.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.8
Trailing annual dividend yield 0.0472%
5-Year annual dividend yield -
Payout ratio 0.75
Dividend Date 8 May 2026
Ex-Dividend Date 8 Apr 2026
Last split factor 727:722
Last split Date 4 Sep 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.18%
Operating margin 0.07%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.43
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.8
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.11
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.59%
Book value per share (mrq) 16.55
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
